Progyny, Inc.
PGNYNASDAQHealthcare● Active
$25.92
+$0.06(+0.23%)
Market Cap$2.0B
P/E Ratio—
52W High$28.75
52W Low$16.1
Progyny, Inc. (PGNY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PGNY · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.29
Est. $0.26 · +13.3%
Revenue
$0.33B
Est. $0.33B · +0.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS🔥 11-Quarter EPS Beat Streak
PGNY reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.50 | — | — | — | $0.35B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.26 | $0.29 | +13.3% | $0.33B | $0.33B | +0.6% |
| ▲ Q1 FY2026 | Feb 26, 2026 | $0.15 | $0.15 | +2.0% | $0.32B | $0.31B | +3.6% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.39 | $0.45 | +15.4% | $0.31B | $0.31B | -0.3% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.44 | $0.48 | +9.1% | $0.33B | $0.30B | +11.2% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.45 | $0.48 | +6.7% | $0.32B | $0.31B | +5.3% |
| ▲ Q1 FY2025 | Feb 27, 2025 | $0.37 | $0.42 | +13.5% | $0.30B | $0.28B | +7.6% |
| ▲ Q4 FY2024 | Nov 12, 2024 | $0.37 | $0.40 | +8.1% | $0.29B | $0.28B | +3.4% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.50
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.29
EPS Est.
$0.26
EPS Surpr.
+13.3%
Revenue
$0.33B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$0.15
EPS Est.
$0.15
EPS Surpr.
+2.0%
Revenue
$0.32B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.45
EPS Est.
$0.39
EPS Surpr.
+15.4%
Revenue
$0.31B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.48
EPS Est.
$0.44
EPS Surpr.
+9.1%
Revenue
$0.33B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.48
EPS Est.
$0.45
EPS Surpr.
+6.7%
Revenue
$0.32B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$0.42
EPS Est.
$0.37
EPS Surpr.
+13.5%
Revenue
$0.30B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
$0.40
EPS Est.
$0.37
EPS Surpr.
+8.1%
Revenue
$0.29B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.25 | $0.26 | $0.27 | 3 |
| Q3 FY2028 | $0.31 | $0.32 | $0.33 | 2 |
| Q2 FY2028 | $0.27 | $0.28 | $0.29 | 2 |
| Q1 FY2028 | $0.23 | $0.24 | $0.25 | 3 |
| Q4 FY2027 | $0.34 | $0.34 | $0.35 | 2 |
| Q3 FY2027 | $0.33 | $0.34 | $0.35 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.4B | $0.4B | $0.4B | 2 |
| Q3 FY2028 | $0.4B | $0.4B | $0.4B | 2 |
| Q2 FY2028 | $0.4B | $0.4B | $0.4B | 2 |
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 2 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +13.3% | $18.70 | $19.16 | +2.46% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +2.0% | $21.33 | $22.25 | +4.31% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +15.4% | $18.88 | $18.01 | -4.61% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +9.1% | $23.49 | $23.06 | -1.83% |
| ▲ Q2 FY2025 | May 8, 2025 | +6.7% | $23.42 | $23.37 | -0.21% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +13.5% | $23.00 | $22.88 | -0.52% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +8.1% | $17.06 | $17.18 | +0.70% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +19.4% | $25.32 | $25.74 | +1.66% |
Q2 FY2026+2.46%
Report Date
May 7, 2026
EPS Beat/Miss
+13.3%
Price Before
$18.70
Price After
$19.16
Q1 FY2026+4.31%
Report Date
Feb 26, 2026
EPS Beat/Miss
+2.0%
Price Before
$21.33
Price After
$22.25
Q4 FY2025-4.61%
Report Date
Nov 6, 2025
EPS Beat/Miss
+15.4%
Price Before
$18.88
Price After
$18.01
Q3 FY2025-1.83%
Report Date
Aug 7, 2025
EPS Beat/Miss
+9.1%
Price Before
$23.49
Price After
$23.06
Q2 FY2025-0.21%
Report Date
May 8, 2025
EPS Beat/Miss
+6.7%
Price Before
$23.42
Price After
$23.37
Q1 FY2025-0.52%
Report Date
Feb 27, 2025
EPS Beat/Miss
+13.5%
Price Before
$23.00
Price After
$22.88
Q4 FY2024+0.70%
Report Date
Nov 12, 2024
EPS Beat/Miss
+8.1%
Price Before
$17.06
Price After
$17.18
Q3 FY2024+1.66%
Report Date
Aug 6, 2024
EPS Beat/Miss
+19.4%
Price Before
$25.32
Price After
$25.74
Avg Beat Reaction+0.24%
Beat Rate8 / 8 quarters
Largest Move-4.61% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PGNY ends December
Progyny, Inc. (PGNY) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.29 — beating the analyst consensus of $0.26 by +13.3%. PGNY has beaten EPS estimates for 11 consecutive quarters.
Each quarter, investors track PGNY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PGNY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PGNY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PGNY earnings · 5 questionsProgyny, Inc.'s next earnings report is expected around TBD. PGNY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PGNY historically reports after market close (AMC).
PGNY earnings datewhen is PGNY earningsPGNY next earnings datewhen does PGNY report earningsPGNY earnings calendar
▸ Source: FMP · Progyny, Inc. SEC filings · US GAAP · Progyny, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026